Tilak Mandadi
Insider
First SEC filing: May 11, 2026 · Latest: May 11, 2026
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net: $-6,230,379
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | CVS | S | 69,551 | $89.58 | $6,230,379 | 10,133 Direct | -87.28% | Disposed | -3.4% (price as of 2026-10-05) |
| April 1, 2026 | CVS | F | 3,634 | $72.49 | $263,429 | 79,684 Direct | -4.36% | Disposed | 19.4% (price as of 2026-10-05) |
| March 31, 2026 | CVS | A | 143,712 | $71.82 | $10,321,396 | 143,712 Direct | · | Acquired | 20.5% (price as of 2026-10-05) |
| March 31, 2026 | CVS | A | 22,277 | $71.82 | $1,599,934 | 88,543 Direct | +33.62% | Acquired | 20.5% (price as of 2026-10-05) |
| Nov. 30, 2025 | CVS | F | 6,575 | $80.36 | $528,367 | 74,085 Direct | -8.15% | Disposed | 7.7% (price as of 2026-10-05) |
| Aug. 31, 2025 | CVS | F | 12,834 | $73.15 | $938,807 | 63,952 Direct | -16.71% | Disposed | 18.3% (price as of 2026-10-05) |
| April 1, 2025 | CVS | A | 87,336 | $67.98 | $5,937,101 | 87,336 Direct | · | Acquired | 27.3% (price as of 2026-10-05) |
| April 1, 2025 | CVS | A | 20,594 | $67.98 | $1,399,980 | 116,257 Direct | +21.53% | Acquired | 27.3% (price as of 2026-10-05) |
| April 1, 2025 | CVS | F | 995 | $67.98 | $67,640 | 43,503 Direct | -2.24% | Disposed | 27.3% (price as of 2026-10-05) |
| Nov. 30, 2024 | CVS | A | 50,125 | $59.85 | $2,999,981 | 99,747 Direct | +101.01% | Acquired | 44.6% (price as of 2026-10-05) |
| Aug. 31, 2024 | CVS | F | 13,097 | $57.24 | $749,672 | 40,414 Direct | -24.48% | Disposed | 51.2% (price as of 2026-10-05) |
| April 1, 2024 | CVS | A | 67,920 | $79.56 | $5,403,715 | 67,920 Direct | · | Acquired | 8.8% (price as of 2026-10-05) |
| April 1, 2024 | CVS | A | 16,339 | · | · | 82,904 Direct | +24.55% | Acquired | (price as of 2026-10-05) |
| Aug. 31, 2023 | CVS | F | 13,053 | $65.17 | $850,664 | 20,229 Direct | -39.22% | Disposed | 32.8% (price as of 2026-10-05) |
| April 1, 2023 | CVS | A | 96,496 | $74.31 | $7,170,618 | 96,496 Direct | · | Acquired | 16.4% (price as of 2026-10-05) |
| Aug. 31, 2022 | CVS | A | 99,847 | · | · | 99,847 Direct | · | Acquired | (price as of 2026-10-05) |
| June 15, 2022 | MGM | A | 1 | · | · | 7,327 Direct | +0.01% | Acquired | (price as of 2026-10-05) |
| June 15, 2022 | MGM | A | 2 | · | · | 22,921 Direct | +0.01% | Acquired | (price as of 2026-10-05) |
| June 15, 2022 | MGM | A | 6 | · | · | 75,020 Direct | +0.01% | Acquired | (price as of 2026-10-05) |
| March 15, 2022 | MGM | A | 0 | · | · | 7,326 Direct | 0.00% | Acquired | (price as of 2026-10-05) |
| March 15, 2022 | MGM | A | 1 | · | · | 22,919 Direct | 0.00% | Acquired | (price as of 2026-10-05) |
| March 15, 2022 | MGM | A | 5 | · | · | 75,014 Direct | +0.01% | Acquired | (price as of 2026-10-05) |
| Feb. 24, 2022 | MGM | A | 7,326 | · | · | 7,326 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 15, 2021 | MGM | A | 1 | · | · | 22,917 Direct | 0.00% | Acquired | (price as of 2026-10-05) |
| Dec. 15, 2021 | MGM | A | 5 | · | · | 75,009 Direct | +0.01% | Acquired | (price as of 2026-10-05) |
| Oct. 4, 2021 | MGM | A | 22,916 | · | · | 22,916 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 15, 2021 | MGM | A | 5 | · | · | 75,005 Direct | +0.01% | Acquired | (price as of 2026-10-05) |
| Aug. 2, 2021 | MGM | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 31, 2026 | CVS | Stock Option [F3] | Common Stock | $71.82 | March 31, 2036 | 143,712 | Acquired |
| April 1, 2025 | CVS | Stock Option [F3] | Common Stock | $67.98 | April 1, 2035 | 87,336 | Acquired |
| April 1, 2024 | CVS | Stock Option [F2] | Common Stock | $79.56 | April 1, 2034 | 67,920 | Acquired |
| April 1, 2023 | CVS | Stock Option [F2] | Common Stock | $74.31 | April 1, 2033 | 96,496 | Acquired |
| June 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Feb. 24, 2026 | 1 | Acquired |
| June 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Oct. 4, 2025 | 2 | Acquired |
| June 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Aug. 2, 2023 | 6 | Acquired |
| March 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Feb. 24, 2026 | 0 | Acquired |
| March 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Oct. 4, 2025 | 1 | Acquired |
| March 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Aug. 2, 2023 | 5 | Acquired |
| Feb. 24, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Feb. 24, 2026 | 7,326 | Acquired |
| Dec. 15, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Oct. 4, 2025 | 1 | Acquired |
| Dec. 15, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Aug. 2, 2023 | 5 | Acquired |
| Oct. 4, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Oct. 4, 2025 | 22,916 | Acquired |
| Sept. 15, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Aug. 2, 2023 | 5 | Acquired |
| Aug. 2, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND | · | Aug. 2, 2023 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1,000,000 | · | · | · | $2,561,000 | · | $416,755 | $10,977,716 |
| 2024 | $1,000,000 | · | · | · | $583,000 | · | $278,511 | $11,361,343 |
| 2023 | $1,000,000 | · | $4,874,990 | $1,624,993 | $1,246,000 | · | $135,862 | $8,881,845 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $416,849 | $637,500 | $5,352,750 | · | $956,250 | · | $14,632 | $7,377,981 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.